Neovasc Inc. (Nasdaq: NVCN) to Ring The Nasdaq Stock Market Closing Bell



Neovasc Inc. (Nasdaq:NVCN), a specialty medical device company developing the Tiara for the transcatheter treatment of mitral valve disease and the Reducer for the treatment of refractory angina, will visit the Nasdaq MarketSite in Times Square.

In honor of the occasion, Alexei Marko, Chief Executive Officer, and Chris Clark, Chief Financial Officer, will ring the Closing Bell.


Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio


Tuesday, January 13, 2015 – 3:45 p.m. to 4:00 p.m. ET

Neovasc Inc. Media Contact:
Chris Clark
(604) 248-4138

Nasdaq MarketSite:
Christine Barna
(646) 441-5310

Feed Information:

Fiber Line (Encompass Waterfront): 4463

Gal 3C/06C 95.05 degrees West
18 mhz Lower
DL 3811 Vertical
FEC 3/4
SR 13.235
DR 18.295411
MOD 4:2:0

Social Media:

For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies please visit our Facebook page at: http://www.facebook.com/NASDAQ.

For photos from ceremonies and events visit our Instagram Page: http://instagram.com/nasdaq

For news tweets, please visit our Twitter page at: http://twitter.com/nasdaq

For exciting viral content and ceremony photos visit Tumblr Page: http://nasdaq.tumblr.com/


A webcast of the Nasdaq Closing Bell will be available at: https://new.livestream.com/nasdaq/live or http://www.nasdaq.com/about/marketsitetowervideo.asx


To obtain a hi-resolution photograph of the Market Close, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market close of your choice.

About Neovasc Inc. (Nasdaq:NVCN):

Neovasc is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include the Tiara™ technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer™ for the treatment of refractory angina and a line of advanced biological tissue products that are used as key components in third-party medical products including transcatheter heart valves. For more information, visit: www.neovasc.com.

About Nasdaq:

Nasdaq (Nasdaq:NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today’s global capital markets. As the creator of the world’s first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,500 listed companies with a market value of over $8.8 trillion and more than 10,000 corporate clients. To learn more, visit www.nasdaq.com/ambition or www.nasdaqomx.com.


Source:The NASDAQ OMX Group, Inc.